TRPM3 as a novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain. Aloi VD, Pinto SJPC, Van Bree R, Luyten K, et al. Pain 2023 Apr 19. doi: 10.1097/j.pain.0000000000002906.

Read + Share

Amedeo Smart

Independent Medical Education

Aloi VD, Pinto SJPC, Van Bree R, Luyten K, et al. TRPM3 as a novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain. Pain 2023 Apr 19. doi: 10.1097/j.pain.0000000000002906.
PMID: 37079852